CD4 and myeloid sarcoma: In addition, cyclic APLs, including cyclo (91–99) (Ala96) MBP87–99 and cyclo (87–99) (Arg91, Ala96) MBP87–99, have a significant impact on the proliferation and cytokine profile of MBP87–99-specific CD4+ T cells from MS patients.